Solarvest BioEnergy Stock Forecast, Price & News

+0.01 (+3.70 %)
(As of 07/30/2021 03:39 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume17,962 shs
Average Volume141,030 shs
Market CapitalizationC$15.45 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SVS News and Ratings via Email

Sign-up to receive the latest news and ratings for Solarvest BioEnergy and its competitors with MarketBeat's FREE daily newsletter.

About Solarvest BioEnergy

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally. Its algal-based production systems are used to produce organic omega nutraceuticals and bio-pharmaceutical active ingredients/therapies. The company develops algae strains for the food enhancement and nutraceutical markets; and producing therapeutic proteins. It has a collaborative research and development agreement with FSD Pharma Inc. to develop algae-based pharmaceutical grade cannabinoids. The company was incorporated in 2005 and is based in Vancouver, Canada.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.99 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Solarvest BioEnergy (CVE:SVS) Frequently Asked Questions

What stocks does MarketBeat like better than Solarvest BioEnergy?

Wall Street analysts have given Solarvest BioEnergy a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Solarvest BioEnergy wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Solarvest BioEnergy's stock price been impacted by Coronavirus (COVID-19)?

Solarvest BioEnergy's stock was trading at C$0.08 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SVS shares have increased by 250.0% and is now trading at C$0.28.
View which stocks have been most impacted by COVID-19

Who are Solarvest BioEnergy's key executives?

Solarvest BioEnergy's management team includes the following people:
  • Mr. Kenneth Anthony Cawkell B.A., LL.B., Chairman & Corp. Sec. (Age 70)
  • Mr. Gerri J. Greenham, Pres, CEO & Director (Age 70)
  • Mr. Garth Greenham, Chief Operating Officer

Who are some of Solarvest BioEnergy's key competitors?

What is Solarvest BioEnergy's stock symbol?

Solarvest BioEnergy trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SVS."

How do I buy shares of Solarvest BioEnergy?

Shares of SVS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Solarvest BioEnergy's stock price today?

One share of SVS stock can currently be purchased for approximately C$0.28.

How much money does Solarvest BioEnergy make?

Solarvest BioEnergy has a market capitalization of C$15.45 million and generates C$12,370.00 in revenue each year.

What is Solarvest BioEnergy's official website?

The official website for Solarvest BioEnergy is

Where are Solarvest BioEnergy's headquarters?

Solarvest BioEnergy is headquartered at 439 Helmcken St, VANCOUVER, BC V6B 2E6, Canada.

How can I contact Solarvest BioEnergy?

Solarvest BioEnergy's mailing address is 439 Helmcken St, VANCOUVER, BC V6B 2E6, Canada. The company can be reached via phone at +1-604-6843323.

This page was last updated on 7/31/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.